PEGylated and targeted extracellular vesicles display enhanced cell specificity and circulation time

被引:493
作者
Kooijmans, S. A. A. [1 ]
Fliervoet, L. A. L. [2 ]
van der Meel, R. [1 ,3 ]
Fens, M. H. A. M. [1 ]
Heijnen, H. F. G. [1 ]
Henegouwen, P. M. P. van Bergen En [4 ]
Vader, P. [1 ]
Schiffelers, R. M. [1 ]
机构
[1] Univ Med Ctr Utrecht, Dept Clin Chem & Haematol, Correspondence G03-550,Heidelberglaan 100, NL-3508 GA Utrecht, Netherlands
[2] Univ Utrecht, Utrecht Inst Pharmaceut Sci, Dept Pharmaceut, Utrecht, Netherlands
[3] Univ British Columbia, Dept Biochem & Mol Biol, Vancouver, BC V6T 1Z3, Canada
[4] Univ Utrecht, Dept Biol, Div Cell Biol, Utrecht, Netherlands
基金
欧洲研究理事会;
关键词
Extracellular vesicles; Drug delivery; Polyethylene glycol; Circulation time; Targeting; Nanobody; DRUG-DELIVERY SYSTEMS; MEMBRANE-VESICLES; THERAPEUTIC APPLICATIONS; INTERFERING RNA; LIPOSOMES; EXOSOMES; PROTEIN; BIODISTRIBUTION; POSTINSERTION; NANOPARTICLES;
D O I
10.1016/j.jconrel.2016.01.009
中图分类号
O6 [化学];
学科分类号
070301 [无机化学];
摘要
Extracellular vesicles (EVs) are increasingly being recognized as candidate drug delivery systems due to their ability to functionally transfer biological cargo between cells. However, the therapeutic applicability of EVs may be limited due to a lack of cell-targeting specificity and rapid clearance of exogenous EVs from the circulation. In order to improve EV characteristics for drug delivery to tumor cells, we have developed a novel method for decorating EVs with targeting ligands conjugated to polyethylene glycol (PEG). Nanobodies specific for the epidermal growth factor receptor (EGFR) were conjugated to phospholipid (DMPE)-PEG derivatives to prepare nanobody-PEG-micelles. When micelles were mixed with EVs derived from Neuro2A cells or platelets, a temperature-dependent transfer of nanobody-PEG-lipids to the EV membranes was observed, indicative of a 'post-insertion' mechanism. This process did not affect EV morphology, size distribution, or protein composition. After introduction of PEG-conjugated control nanobodies to EVs, cellular binding was compromised due to the shielding properties of PEG. However, specific binding to EGFR-overexpressing tumor cells was dramatically increased when EGFR-specific nanobodies were employed. Moreover, whereas unmodified EVs were rapidly cleared from the circulation within 10 min after intravenous injection in mice, EVs modified with nanobody-PEG-lipids were still detectable in plasma for longer than 60 min post-injection. In conclusion, we propose post-insertion as a novel technique to confer targeting capacity to isolated EVs, circumventing the requirement to modify EV-secreting cells. Importantly, insertion of ligand-conjugated PEG-derivatized phospholipids in EV membranes equips EVs with improved cell specificity and prolonged circulation times, potentially increasing EV accumulation in targeted tissues and improving cargo delivery. (C) 2015 Elsevier B.V. All rights reserved.
引用
收藏
页码:77 / 85
页数:9
相关论文
共 71 条
[1]
Liposomal drug delivery systems: From concept to clinical applications [J].
Allen, Theresa M. ;
Cullis, Pieter R. .
ADVANCED DRUG DELIVERY REVIEWS, 2013, 65 (01) :36-48
[2]
Allen TM, 2002, CELL MOL BIOL LETT, V7, P889
[3]
Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes [J].
Alvarez-Erviti, Lydia ;
Seow, Yiqi ;
Yin, HaiFang ;
Betts, Corinne ;
Lakhal, Samira ;
Wood, Matthew J. A. .
NATURE BIOTECHNOLOGY, 2011, 29 (04) :341-U179
[4]
Effects of phosphatidylserine on membrane incorporation and surface protection properties of exchangeable poly(ethylene glycol)-conjugated lipids [J].
Chiu, GNC ;
Bally, MB ;
Mayer, LD .
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES, 2002, 1560 (1-2) :37-50
[5]
Drug therapy: EGFR antagonists in cancer treatment [J].
Ciardiello, Fortunato ;
Tortora, Giampaolo .
NEW ENGLAND JOURNAL OF MEDICINE, 2008, 358 (11) :1160-1174
[6]
Denzer K, 2000, J CELL SCI, V113, P3365
[7]
Induced refolding of a temperature denatured llama heavy-chain antibody fragment by its antigen [J].
Dolk, E ;
van Vliet, C ;
Perez, JMJ ;
Vriend, G ;
Darbon, H ;
Ferrat, G ;
Cambillau, C ;
Frenken, LGJ ;
Verrips, T .
PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS, 2005, 59 (03) :555-564
[8]
Influence of poly(ethylene glycol) grafting density and polymer length on liposomes: Relating plasma circulation lifetimes to protein binding [J].
Dos Santos, Nancy ;
Allen, Christine ;
Doppen, Anne-Marie ;
Anantha, Malathi ;
Cox, Kelly A. K. ;
Gallagher, Ryan C. ;
Karlsson, Goran ;
Edwards, Katanna ;
Kenner, Gail ;
Samuels, Lacey ;
Webb, Murray S. ;
Bally, Marcel B. .
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES, 2007, 1768 (06) :1367-1377
[9]
Extracellular vesicles: biology and emerging therapeutic opportunities [J].
EL Andaloussi, Samir ;
Maeger, Imre ;
Breakefield, Xandra O. ;
Wood, Matthew J. A. .
NATURE REVIEWS DRUG DISCOVERY, 2013, 12 (05) :348-358
[10]
Biophysical properties of camelid VHH domains compared to those of human VH3 domains [J].
Ewert, S ;
Cambillau, C ;
Conrath, K ;
Plückthun, A .
BIOCHEMISTRY, 2002, 41 (11) :3628-3636